Experiment: 9Q2Z

Solution Structure of G12C mutant GppNHp-bound T35S KRAS4b

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	1D 1H	0.8 mM [U-100% 13C; U-100% 15N] KRAS protein, 0.02 % NaN3, 0.8 mM GppNHp, 1 mM TCEP, 100 mM KCl, 50 mM NaCl, 2 mM MgCl2, 20 mM MES, 250 uM DSS, 7 % [U-2H] D2O, 93 % H2O	93% H2O/7% D2O	0.15 M	6.5	1 atm	298	Bruker AVANCE III 600
2	2D 1H-15N HSQC	0.8 mM [U-100% 13C; U-100% 15N] KRAS protein, 0.02 % NaN3, 0.8 mM GppNHp, 1 mM TCEP, 100 mM KCl, 50 mM NaCl, 2 mM MgCl2, 20 mM MES, 250 uM DSS, 7 % [U-2H] D2O, 93 % H2O	93% H2O/7% D2O	0.15 M	6.5	1 atm	298	Bruker AVANCE III 600
3	2D 1H-13C HSQC	0.8 mM [U-100% 13C; U-100% 15N] KRAS protein, 0.02 % NaN3, 0.8 mM GppNHp, 1 mM TCEP, 100 mM KCl, 50 mM NaCl, 2 mM MgCl2, 20 mM MES, 250 uM DSS, 7 % [U-2H] D2O, 93 % H2O	93% H2O/7% D2O	0.15 M	6.5	1 atm	298	Bruker AVANCE III 600
4	3D HNCACB	0.8 mM [U-100% 13C; U-100% 15N] KRAS protein, 0.02 % NaN3, 0.8 mM GppNHp, 1 mM TCEP, 100 mM KCl, 50 mM NaCl, 2 mM MgCl2, 20 mM MES, 250 uM DSS, 7 % [U-2H] D2O, 93 % H2O	93% H2O/7% D2O	0.15 M	6.5	1 atm	298	Bruker AVANCE III 600
5	3D CBCA(CO)NH	0.8 mM [U-100% 13C; U-100% 15N] KRAS protein, 0.02 % NaN3, 0.8 mM GppNHp, 1 mM TCEP, 100 mM KCl, 50 mM NaCl, 2 mM MgCl2, 20 mM MES, 250 uM DSS, 7 % [U-2H] D2O, 93 % H2O	93% H2O/7% D2O	0.15 M	6.5	1 atm	298	Bruker AVANCE III 600
6	3D HNCA	0.8 mM [U-100% 13C; U-100% 15N] KRAS protein, 0.02 % NaN3, 0.8 mM GppNHp, 1 mM TCEP, 100 mM KCl, 50 mM NaCl, 2 mM MgCl2, 20 mM MES, 250 uM DSS, 7 % [U-2H] D2O, 93 % H2O	93% H2O/7% D2O	0.15 M	6.5	1 atm	298	Bruker AVANCE III 600
7	3D HN(CO)CA	0.8 mM [U-100% 13C; U-100% 15N] KRAS protein, 0.02 % NaN3, 0.8 mM GppNHp, 1 mM TCEP, 100 mM KCl, 50 mM NaCl, 2 mM MgCl2, 20 mM MES, 250 uM DSS, 7 % [U-2H] D2O, 93 % H2O	93% H2O/7% D2O	0.15 M	6.5	1 atm	298	Bruker AVANCE III 600
8	3D HNCO	0.8 mM [U-100% 13C; U-100% 15N] KRAS protein, 0.02 % NaN3, 0.8 mM GppNHp, 1 mM TCEP, 100 mM KCl, 50 mM NaCl, 2 mM MgCl2, 20 mM MES, 250 uM DSS, 7 % [U-2H] D2O, 93 % H2O	93% H2O/7% D2O	0.15 M	6.5	1 atm	298	Bruker AVANCE III 600
9	3D HN(CA)CO	0.8 mM [U-100% 13C; U-100% 15N] KRAS protein, 0.02 % NaN3, 0.8 mM GppNHp, 1 mM TCEP, 100 mM KCl, 50 mM NaCl, 2 mM MgCl2, 20 mM MES, 250 uM DSS, 7 % [U-2H] D2O, 93 % H2O	93% H2O/7% D2O	0.15 M	6.5	1 atm	298	Bruker AVANCE III 600
10	3D HBHA(CO)NH	0.8 mM [U-100% 13C; U-100% 15N] KRAS protein, 0.02 % NaN3, 0.8 mM GppNHp, 1 mM TCEP, 100 mM KCl, 50 mM NaCl, 2 mM MgCl2, 20 mM MES, 250 uM DSS, 7 % [U-2H] D2O, 93 % H2O	93% H2O/7% D2O	0.15 M	6.5	1 atm	298	Varian INOVA 600
11	3D H(CCO)NH	0.8 mM [U-100% 13C; U-100% 15N] KRAS protein, 0.02 % NaN3, 0.8 mM GppNHp, 1 mM TCEP, 100 mM KCl, 50 mM NaCl, 2 mM MgCl2, 20 mM MES, 250 uM DSS, 7 % [U-2H] D2O, 93 % H2O	93% H2O/7% D2O	0.15 M	6.5	1 atm	298	Varian INOVA 600
12	3D C(CO)NH	0.8 mM [U-100% 13C; U-100% 15N] KRAS protein, 0.02 % NaN3, 0.8 mM GppNHp, 1 mM TCEP, 100 mM KCl, 50 mM NaCl, 2 mM MgCl2, 20 mM MES, 250 uM DSS, 7 % [U-2H] D2O, 93 % H2O	93% H2O/7% D2O	0.15 M	6.5	1 atm	298	Varian INOVA 600
13	3D CCH-TOCSY	0.8 mM [U-100% 13C; U-100% 15N] KRAS protein, 0.02 % NaN3, 0.8 mM GppNHp, 1 mM TCEP, 100 mM KCl, 50 mM NaCl, 2 mM MgCl2, 20 mM MES, 250 uM DSS, 7 % [U-2H] D2O, 93 % H2O	93% H2O/7% D2O	0.15 M	6.5	1 atm	298	Varian INOVA 600
14	3D HCCH-TOCSY	0.8 mM [U-100% 13C; U-100% 15N] KRAS protein, 0.02 % NaN3, 0.8 mM GppNHp, 1 mM TCEP, 100 mM KCl, 50 mM NaCl, 2 mM MgCl2, 20 mM MES, 250 uM DSS, 7 % [U-2H] D2O, 93 % H2O	93% H2O/7% D2O	0.15 M	6.5	1 atm	298	Varian INOVA 600
15	3D HCCH-COSY	0.8 mM [U-100% 13C; U-100% 15N] KRAS protein, 0.02 % NaN3, 0.8 mM GppNHp, 1 mM TCEP, 100 mM KCl, 50 mM NaCl, 2 mM MgCl2, 20 mM MES, 250 uM DSS, 7 % [U-2H] D2O, 93 % H2O	93% H2O/7% D2O	0.15 M	6.5	1 atm	298	Varian INOVA 600
16	3D 15N-separated NOESY	0.8 mM [U-100% 13C; U-100% 15N] KRAS protein, 0.02 % NaN3, 0.8 mM GppNHp, 1 mM TCEP, 100 mM KCl, 50 mM NaCl, 2 mM MgCl2, 20 mM MES, 250 uM DSS, 7 % [U-2H] D2O, 93 % H2O	93% H2O/7% D2O	0.15 M	6.5	1 atm	298	Bruker AVANCE III 750
17	3D 13C-separated NOESY	0.8 mM [U-100% 13C; U-100% 15N] KRAS protein, 0.02 % NaN3, 0.8 mM GppNHp, 1 mM TCEP, 100 mM KCl, 50 mM NaCl, 2 mM MgCl2, 20 mM MES, 250 uM DSS, 7 % [U-2H] D2O, 93 % H2O	93% H2O/7% D2O	0.15 M	6.5	1 atm	298	Bruker AVANCE III 750
18	T1/R1 relaxation	0.8 mM [U-100% 13C; U-100% 15N] KRAS protein, 0.02 % NaN3, 0.8 mM GppNHp, 1 mM TCEP, 100 mM KCl, 50 mM NaCl, 2 mM MgCl2, 20 mM MES, 250 uM DSS, 7 % [U-2H] D2O, 93 % H2O	93% H2O/7% D2O	0.15 M	6.5	1 atm	298	Bruker AVANCE III 600
19	T2/R2 relaxation	0.8 mM [U-100% 13C; U-100% 15N] KRAS protein, 0.02 % NaN3, 0.8 mM GppNHp, 1 mM TCEP, 100 mM KCl, 50 mM NaCl, 2 mM MgCl2, 20 mM MES, 250 uM DSS, 7 % [U-2H] D2O, 93 % H2O	93% H2O/7% D2O	0.15 M	6.5	1 atm	298	Bruker AVANCE III 600
20	1H-15N heteronoe	0.8 mM [U-100% 13C; U-100% 15N] KRAS protein, 0.02 % NaN3, 0.8 mM GppNHp, 1 mM TCEP, 100 mM KCl, 50 mM NaCl, 2 mM MgCl2, 20 mM MES, 250 uM DSS, 7 % [U-2H] D2O, 93 % H2O	93% H2O/7% D2O	0.15 M	6.5	1 atm	298	Bruker AVANCE III 600
21	2D 1H-15N HSQC NH2 only	0.8 mM [U-100% 13C; U-100% 15N] KRAS protein, 0.02 % NaN3, 0.8 mM GppNHp, 1 mM TCEP, 100 mM KCl, 50 mM NaCl, 2 mM MgCl2, 20 mM MES, 250 uM DSS, 7 % [U-2H] D2O, 93 % H2O	93% H2O/7% D2O	0.15 M	6.5	1 atm	298	Bruker AVANCE III 600
22	T1rho/R1rho relaxation	0.8 mM [U-100% 13C; U-100% 15N] KRAS protein, 0.02 % NaN3, 0.8 mM GppNHp, 1 mM TCEP, 100 mM KCl, 50 mM NaCl, 2 mM MgCl2, 20 mM MES, 250 uM DSS, 7 % [U-2H] D2O, 93 % H2O	93% H2O/7% D2O	0.15 M	6.5	1 atm	298	Bruker AVANCE III 600
23	2D HBCBCGCDCEHE	0.8 mM [U-100% 13C; U-100% 15N] KRAS protein, 0.02 % NaN3, 0.8 mM GppNHp, 1 mM TCEP, 100 mM KCl, 50 mM NaCl, 2 mM MgCl2, 20 mM MES, 250 uM DSS, 7 % [U-2H] D2O, 93 % H2O	93% H2O/7% D2O	0.15 M	6.5	1 atm	298	Bruker AVANCE III 750
24	2D HBCBCGCDHD	0.8 mM [U-100% 13C; U-100% 15N] KRAS protein, 0.02 % NaN3, 0.8 mM GppNHp, 1 mM TCEP, 100 mM KCl, 50 mM NaCl, 2 mM MgCl2, 20 mM MES, 250 uM DSS, 7 % [U-2H] D2O, 93 % H2O	93% H2O/7% D2O	0.15 M	6.5	1 atm	298	Bruker AVANCE III 750
25	3D 1H-13C NOESY aliphatic	0.8 mM [U-100% 13C; U-100% 15N] KRAS protein, 0.02 % NaN3, 0.8 mM GppNHp, 1 mM TCEP, 100 mM KCl, 50 mM NaCl, 2 mM MgCl2, 20 mM MES, 250 uM DSS, 7 % [U-2H] D2O, 93 % H2O	93% H2O/7% D2O	0.15 M	6.5	1 atm	298	Bruker AVANCE III 750
26	3D 1H-13C NOESY aromatic	0.8 mM [U-100% 13C; U-100% 15N] KRAS protein, 0.02 % NaN3, 0.8 mM GppNHp, 1 mM TCEP, 100 mM KCl, 50 mM NaCl, 2 mM MgCl2, 20 mM MES, 250 uM DSS, 7 % [U-2H] D2O, 93 % H2O	93% H2O/7% D2O	0.15 M	6.5	1 atm	298	Bruker AVANCE III 750

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE III	600
2	Bruker	AVANCE III	750
3	Varian	INOVA	600

NMR Refinement
Method	Details	Software
torsion angle dynamics		CNS

NMR Ensemble Information
Conformer Selection Criteria	target function
Conformers Calculated Total Number	100
Conformers Submitted Total Number	20
Representative Model	1 (target function & lower energy)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	processing	NMRPipe	v10.9	Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax
2	processing	NMRDraw	v10.9	Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax
3	chemical shift assignment	CCNMR	v2.4	Vranken WF, Boucher W, Stevens TJ, Fogh RH, Pajon A, Llinas M, Ulrich EL, Markley JL, Ionides J, and Laue ED
5	structure calculation	CYANA	3.98.15	Guntert, Mumenthaler and Wuthrich
6	refinement	CNS	1.3	Brunger, Adams, Clore, Gros, Nilges and Read
7	peak picking	CcpNmr Analysis	2.4	CCPN

RCSB PDB is hosted by

RCSB PDB is a member of

RCSB Partners
Nucleic Acid Knowledgebase

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729. RCSB PDB uses resources of the National Energy Research Scientific Computing Center (NERSC), a Department of Energy User Facility.

9Q2Z | pdb_00009q2z

Solution Structure of G12C mutant GppNHp-bound T35S KRAS4b